Loma Linda University

Loma Linda University, a private nonprofit academic health science institution headquartered in Loma Linda, California, acts as a prime recipient and contractor delivering healthcare professional education, medical research, and specialized medical services to federal agencies with no SBA set-aside designations. The university competes on a full-and-open basis across 55 distinct federal customer agencies, anchored by the Department of Veterans Affairs, the Department of the Navy, and the National Institutes of Health.

The institution's federal portfolio reflects a dominant education and training mission. Tuition and fees delivery orders—primarily through the Department of the Navy Bureau of Medicine and Surgery (277 awards, $16.9 million combined potential value) and a parent indefinite delivery contract running through March 2036—represent the largest award concentration, with 362 of 737 total awards classified under education and training services. Representative contract work includes $801,720 in firm fixed-price tuition and fees delivery orders from the Navy (awarded July 2025, December 2025), $797,820 for tuition and fees (January 2026), and smaller quarterly tuition support orders through 2027. Loma Linda also operates under a single-award Basic Ordering Agreement with the Bureau of Medicine and Surgery established in April 2026, establishing a framework for future healthcare services, medical education, and advanced medical technology orders through March 2036.

The university's research and grant footprint centers on biomedical science, health disparities, and clinical workforce development. Recent NIH grants include $631,170 under CFDA 93.121 (Oral Diseases and Disorders Research) for structural-functional studies of gingipain biogenesis in periodontitis (awarded July 2026, performance through April 2030); $776,881 under CFDA 93.837 (Cardiovascular Diseases Research) investigating chronic hypoxia effects on cerebral blood flow in newborns (awarded June 2026, performance through February 2030); and $310,686 under CFDA 93.859 (Biomedical Research and Research Training) for a Basic Biomedical Research T32 graduate training program in the School of Medicine's Integrative Biomedical Graduate Studies PhD program (awarded July 2026, running through June 2031). The university also received $187,824 under CFDA 93.307 (Minority Health and Health Disparities Research) for a pilot randomized controlled trial of a digitally enhanced community health worker intervention for early palliative care in hepatobiliary cancers (awarded September 2026, running through April 2031). Workforce development grants from the Bureau of Health Professionals fund rural residency track programs in family medicine, psychiatry, and addiction medicine, community health worker training (Community Health Worker Training Program, $3 million over three years), and behavioral health workforce education programs—most awarded or ongoing through 2027–2030. The National Telecommunications and Information Administration awarded $6.6 million under CFDA 11.028 (Connecting Minority Communities Pilot Program) to expand online learning, broadband access, and hybrid classroom infrastructure for underserved students, with performance completed January 2025.

Customer concentration is extreme and tilted by dollar value. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 alone represents 28 awards with $306 million in combined potential value, driven by a six-task-order indefinite delivery contract (VA26213D00001) valued at $86.2 million. The Navy (both the Bureau of Medicine and Surgery and Department of the Navy broadly) accounts for 343 awards ($21.4 million combined potential value) but generates most dollars through high-volume, low-value tuition orders and a 296-task-order parent indefinite delivery contract (N0014098G2469) valued at $20.8 million. NIH awards are numerous but individually modest. These five top customers account for 95% of combined potential value across all awards.

Loma Linda holds two notable federal vehicle positions: an indefinite delivery contract with the Navy (N0014098G2469) supporting 296 tuition and fees task orders valued at $20.8 million, and a Basic Ordering Agreement (N0060085G1736) with the Bureau of Medicine and Surgery carrying 32 task orders. The university also operates under a VA indefinite delivery contract and holds additional BOAs with the Navy and other defense customers.

Activity has remained steady at 15–21 awards per year over the past five years, with 737 total awards in the source portfolio. The recompete cliff is minimal—only 23 awards ($477 thousand combined potential value) reach ultimate completion within the next twenty-four months. Obligated dollars ($686.5 million) exceed combined potential value ($362.8 million) by 89%, indicating substantial prior-year spending against indefinite delivery vehicles and rolling tuition orders.

As a subcontractor, Loma Linda participates in nanodrug synthesis and characterization work under Cedars-Sinai Medical Center grants focused on gene therapy and diabetic corneal disease, delivers oral cancer pain research on an NYU-led National Cancer Institute project, and contributes to multi-site NIH trials via subawards from universities including Yale, UC Irvine, the University of Arkansas, and UC San Francisco. The university is the child entity of Loma Linda University Adventist Health Sciences Center, a tax-exempt parent organization.